Clinical Trials in Salt Lake City

Showing 3381-3400 of 16,694 trials

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

NCT03911505

This is a Phase 3, open-label, multicenter study to evaluate the safety, PK, efficacy, PD, and immunogenicity of Cipaglucosidase Alfa/Miglustat treatment in enzyme replacement therapy (ERT)-experienced and ERT-naïve pediatric subjects with Pompe disease, aged 0 to \< 18 years

Pompe Disease (Late-onset)

Amicus Therapeutics21 participantsStarted Feb 2020

Gainesville, Florida, United States • Jacksonville, Florida, United States • Atlanta, Georgia, United States +14 more locations

Active Not RecruitingPhase 3< 1 mile

ABTECT - Maintenance

NCT05535946

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106.

Ulcerative Colitis

Abivax S.A.1,116 participantsStarted Jan 2023

Birmingham, Alabama, United States • Dothan, Alabama, United States • Guntersville, Alabama, United States +551 more locations

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

ABTECT - Maintenance

Find Trials by Condition in Salt Lake City

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

The Myelin Disorders Biorepository Project

Phase 2b Study of GSK4532990 in Adults With NASH

A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer

Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)

Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Safety and Effectiveness Study of OR3O™ Dual Mobility System in THA